𝔖 Bobbio Scriptorium
✦   LIBER   ✦

VP-16 alone and in combination with cisplatin in previously treated patients with small cell lung cancer

✍ Scribed by W. K. Evans; R. Feld; D. Osoba; F. A. Shepherd; J. Dill; G. Deboer

Publisher
John Wiley and Sons
Year
1984
Tongue
English
Weight
600 KB
Volume
53
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Combination chemotherapy with mitomycin-
Combination chemotherapy with mitomycin-C, cisplatin, and vinblastine in the treatment of non-small-cell lung cancer
✍ Niell, Harvey B. ;Griffin, John P. πŸ“‚ Article πŸ“… 1985 πŸ› John Wiley and Sons 🌐 English βš– 443 KB

The drug combination of mitomycin-C, cisplatin, and vinblastine was administered to 30 patients with stage III non-small-cell lung cancer. All patients had a performance status of 50% or greater, had evaluable disease, and had not received previous chemotherapy. The overall response rate was 37% wit

In vivo efficacy of STI571 in xenografte
In vivo efficacy of STI571 in xenografted human small cell lung cancer alone or combined with chemotherapy
✍ Didier Decaudin; Patricia de Cremoux; Xavier Sastre; Jean-Gabriel Judde; Fariba πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 French βš– 227 KB

## Abstract STI571, or imatinib, selectively inhibits BCR/ABL, PDGFR and c‐kit kinase activity. It has been reported that a large proportion of small cell lung cancer (SCLC) cell lines and tumors express c‐kit and that STI571 inhibits tumor cell growth. We therefore investigated the therapeutic eff